Autolus is a clinical-stage biopharmaceutical company focusing on the development of precisely targeted, controlled and highly active T effector cell therapies that are designed to offer cancer patients substantial benefits over existing standard of care.
Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014. Chimeric Antigen Receptor (CAR) T cell therapies have been shown to be effective in some haematological malignancies and may have wide applications as a cancer treatment, with the potential for cure in some patients.
A leader in T-cell programming and manufacturing technology, Autolus works in partnership with physicians and other healthcare providers to extract immune cells from patients, equip them with a receptor that targets the cancer cell and infuse them back into the patient in order to develop therapies which they believe will offer cancer patients substantial benefits over the existing standard of care.
Location: United Kingdom, England, London
Employees: 201-500
Total raised: $136.92M
Founded date: 2014
Investors 3
| Date | Name | Website |
| 18.06.2023 | Syncona Pa... | synconaltd... |
| - | Arix Biosc... | arixbiosci... |
| - | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 26.09.2017 | Series C | $80M | - |
| 04.03.2016 | Series B | $56.92M | - |
Mentions in press and media 18
| Date | Title | Description | Source |
| 12.03.2024 | Autolus Therapeutics receives Medicines and Healthcare produ... | - | globenewsw... |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID... | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of ... | einpresswi... |
| 09.11.2021 | PE Daily: Collibra Hits $5.25 Billion Valuation | Carlyle Ve... | Good day and welcome back. Isaac Taylor brings us the latest news on the soaring valuation of data-t... | wsj.com/ar... |
| 08.11.2021 | Who would take venture dollars from Facebook right now? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 08.11.2021 | Who would take venture dollars from Facebook right now? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 08.11.2021 | Blackstone Life Sciences to invest up to $250 million in Aut... | – One of the largest private financings of a UK biotech company, and the largest from a single sourc... | globenewsw... |
| 07.11.2021 | Blackstone to Invest Up to $250 Million in Autolus Therapeut... | Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeut... | wsj.com/ar... |
| 07.11.2021 | Blackstone to Invest Up to $250 Million in Autolus Therapeut... | - | wsj.com/ar... |
| 30.06.2021 | Autolus Therapeutics : Consolidated Financial Statements (Fo... | Registered Number 11185179 (England & Wales) Annual Report and Accounts for the year ended 31 De... | marketscre... |
| 21.05.2021 | Autolus Therapeutics : Notice of Autolus Therapeutics plc An... | THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the ... | marketscre... |
Show more